Clinical Research Directory
Browse clinical research sites, groups, and studies.
Induce XT™ Bone Graft in Foot and Ankle Fusion
Sponsor: Red Rock Regeneration Inc.
Summary
The goal of this study is to evaluate how effective Induce XT is in patients undergoing foot and/or ankle surgery. Induce XT is a bone graft material used in surgeries to fill gaps where bone is missing, such as during foot and ankle fusion. Participants in the study will have a screening visit to determine eligibility, followed by an assessment on the day of surgery and 5 follow-up visits over 12 months. These visits will include X-rays, pain evaluations, and questionnaires.
Official title: Prospective Evaluation of Induce XT™ Bone Graft in Foot and Ankle Fusion
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2025-05-12
Completion Date
2027-11-01
Last Updated
2025-11-20
Healthy Volunteers
No
Conditions
Interventions
Induce XT™ is a mixture of human cortical bone fibers and microparticulates that have been processed into Natural Matrix Protein® (NMP®) to which cancellous bone microparticulates have been added
Bone graft material is required for successful foot and ankle fusion surgery. Current bone grafting materials include autogenous bone, Augment Bone Graft and demineralized bone matrix (DBM), each of which have limitations. Induce XT is a novel bone graft material that can potentially be used in foot and ankle fusions that may overcome some of these limitations.
Locations (1)
Halifax Infirmary
Halifax, Nova Scotia, Canada